you guys are in for a shock. Especially RBDs. Get ready to be managers again. And DMs. Reps again. You are getting no experience here that is valuable outside of big pharma. Companies are going to small rare disease models. Clueless idiots. All of you. Have a fun party. It’s coming to an end. Way too layered. You still have ABMs for god sake. And too many DMs and way too many RBDs. What a model. Keith,,,, grow a pair
KW has his club and new leaders are awful, oncology is a joke and the people leading are clueless and our development sucks like crazy
You are right, the AML managers are clueless. 8201 looks good but that launch date looks more like 2021 to me. Pain will be gone and I don't think Injectafer will last that long.
Injectafer is done soon. It can sell itself and everyone knows it. They don’t need reps wasting money running around trying to look busy.